BIOLARGO, INC.: chief science officer Kenneth Reay received 566,261 shares

What happened

• Kenneth Reay, chief science officer and director, was granted 566,261 shares at $0.08 per share on Sep 30, 2026, for $45,301 (code A) and disposed of 2,000,000 shares as a gift on Sep 30, 2026 (code G; $0).

Key details

• Transaction dates and prices: Sep 30, 2026 — grant/award 566,261 shares at $0.08; Sep 30, 2026 — gift 2,000,000 shares at $0.00.
• Shares owned after the transaction: the filing reports an aggregate total that includes 22,139,012 shares owned indirectly by Reay through a wholly owned corporation (see footnote F3).
• Relevant footnotes from the filing:
  • F1: the shares acquired are subject to a lock-up restricting sale until the issuer reports gross revenue of at least $40,000,000 for any reported period, or the issuer's market capitalization exceeds $300,000,000, or there is a change in control.
  • F2: the shares were received in exchange for a reduction in amounts owed by the issuer to the reporting person for salary and unreimbursed business expenses (number of shares times the acquisition price).
  • F3: aggregate total includes 22,139,012 shares held indirectly through a wholly owned corporation.
• Filing date and report period: filed Oct 02, 2026; period of report Sep 30, 2026.

Why it may matter

• The 566,261-share transaction was an award/acquisition and the shares are subject to a contractual lock-up per F1 and were issued in exchange for reduction of amounts owed per F2.
• The 2,000,000-share transaction was a gift and was not a market sale.
• This filing does not show why the insider traded or why the company acted.